Texas HCR103 expresses support for the Texas Health and Human Services Commission's application to the Cell and Gene Therapy Access Model.

Texas HCR103 expresses support for the Texas Health and Human Services Commission's application to the Cell and Gene Therapy Access Model through the Centers for Medicare and Medicaid Services. The model aims to expand Medicaid beneficiaries' access to innovative cell and gene therapies, improve health outcomes, and reduce health care costs. The model involves negotiations between the Centers for Medicare and Medicaid Services and pharmaceutical manufacturers to set pricing and outcome measures, forming the basis for contracts between manufacturers and participating states.

Texas HCR103 expresses support for the Texas Health and Human Services Commission's application to the Cell and Gene Therapy Access Model.

Texas HCR103 expresses support for the Texas Health and Human Services Commission's application to the Cell and Gene Therapy Access Model through the Centers for Medicare and Medicaid Services. The model aims to expand Medicaid beneficiaries' access to innovative cell and gene therapies, improve health outcomes, and reduce health care costs. The model involves negotiations between the Centers for Medicare and Medicaid Services and pharmaceutical manufacturers to set pricing and outcome measures, forming the basis for contracts between manufacturers and participating states.